Literature DB >> 21858616

Lack of associations of neuregulin 1 variations with schizophrenia and smooth pursuit eye movement abnormality in a Korean population.

Jeong-Hyun Kim1, Byung-Lae Park, Charisse Flerida A Pasaje, Joon Seol Bae, Chul Soo Park, Boseok Cha, Bong-Jo Kim, Migyung Lee, Woo Hyuk Choi, Tae-Min Shin, Ihn-Geun Choi, Jaeuk Hwang, Insong Koh, Sung-Il Woo, Hyoung Doo Shin.   

Abstract

Schizophrenia is a serious and disabling mental disorder with a high heritability rate. The human neuregulin 1 (NRG1) on 8p12 has been implicated as a candidate gene for schizophrenia. However, controversial results of the associations of NRG1 polymorphisms with schizophrenia and related phenotypes have been reported. In this study, four NRG1 single nucleotide polymorphisms, three in the promoter region, and one nonsynonymous in coding region, were genotyped in a total of 825 subject including 435 schizophrenia cases and 390 normal controls of Korean ethnicity. Although logistic association analysis of NRG1 polymorphisms and haplotypes with schizophrenia showed a nominal association in rs4623364G > C (P = 0.04), the significance disappeared after corrections for multiple testing (corrected P > 0.05). Additional case/control and multiple regression analyses in schizophrenia patients using a method that measures the smooth pursuit eye movement (SPEM) function globally based on natural logarithmic values of the signal/noise ratio also showed no association between NRG1 variants and SPEM abnormality among patients with schizophrenia (P > 0.05). Despite the need for further replications in other cohorts, our findings provide additional supporting information that four variants in NRG1 investigated in this study may not be associated with schizophrenia and its related SPEM function in a Korean population.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21858616     DOI: 10.1007/s12031-011-9619-y

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  31 in total

1.  Neuregulin-1 polymorphism in late onset Alzheimer's disease families with psychoses.

Authors:  Rodney C P Go; Rodney T Perry; Howard Wiener; Susan S Bassett; Deborah Blacker; Bernie Devlin; Robert A Sweet
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2005-11-05       Impact factor: 3.568

2.  Neuregulin genotype and medication response in Finnish patients with schizophrenia.

Authors:  Olli Kampman; Sami Anttila; Ari Illi; Marika Saarela; Riikka Rontu; Kari M Mattila; Esa Leinonen; Terho Lehtimäki
Journal:  Neuroreport       Date:  2004-11-15       Impact factor: 1.837

Review 3.  Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology.

Authors:  Paul J Harrison; Amanda J Law
Journal:  Biol Psychiatry       Date:  2006-01-25       Impact factor: 13.382

4.  The neuregulin 1 promoter polymorphism rs6994992 is not associated with chronic schizophrenia or neurocognition.

Authors:  James J Crowley; Richard S E Keefe; Diana O Perkins; T Scott Stroup; Jeffrey A Lieberman; Patrick F Sullivan
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-10-05       Impact factor: 3.568

Review 5.  Neurodevelopmental mechanisms of schizophrenia: understanding disturbed postnatal brain maturation through neuregulin-1-ErbB4 and DISC1.

Authors:  Hanna Jaaro-Peled; Akiko Hayashi-Takagi; Saurav Seshadri; Atsushi Kamiya; Nicholas J Brandon; Akira Sawa
Journal:  Trends Neurosci       Date:  2009-08-26       Impact factor: 13.837

6.  Neuregulin-1 genotypes and eye movements in schizophrenia.

Authors:  H Magnus Haraldsson; Ulrich Ettinger; Brynja B Magnusdottir; Andres Ingason; Samuel B Hutton; Thordur Sigmundsson; Engilbert Sigurdsson; Hannes Petursson
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-07-03       Impact factor: 5.270

7.  Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia.

Authors:  Tom Walsh; Jon M McClellan; Shane E McCarthy; Anjené M Addington; Sarah B Pierce; Greg M Cooper; Alex S Nord; Mary Kusenda; Dheeraj Malhotra; Abhishek Bhandari; Sunday M Stray; Caitlin F Rippey; Patricia Roccanova; Vlad Makarov; B Lakshmi; Robert L Findling; Linmarie Sikich; Thomas Stromberg; Barry Merriman; Nitin Gogtay; Philip Butler; Kristen Eckstrand; Laila Noory; Peter Gochman; Robert Long; Zugen Chen; Sean Davis; Carl Baker; Evan E Eichler; Paul S Meltzer; Stanley F Nelson; Andrew B Singleton; Ming K Lee; Judith L Rapoport; Mary-Claire King; Jonathan Sebat
Journal:  Science       Date:  2008-03-27       Impact factor: 47.728

Review 8.  The genetics of schizophrenia: glutamate not dopamine?

Authors:  David A Collier; Tao Li
Journal:  Eur J Pharmacol       Date:  2003-11-07       Impact factor: 4.432

9.  A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms.

Authors:  Jeremy Hall; Heather C Whalley; Dominic E Job; Ben J Baig; Andrew M McIntosh; Kathryn L Evans; Pippa A Thomson; David J Porteous; David G Cunningham-Owens; Eve C Johnstone; Stephen M Lawrie
Journal:  Nat Neurosci       Date:  2006-10-29       Impact factor: 24.884

10.  Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia.

Authors:  Cathryn M Lewis; Douglas F Levinson; Lesley H Wise; Lynn E DeLisi; Richard E Straub; Iiris Hovatta; Nigel M Williams; Sibylle G Schwab; Ann E Pulver; Stephen V Faraone; Linda M Brzustowicz; Charles A Kaufmann; David L Garver; Hugh M D Gurling; Eva Lindholm; Hilary Coon; Hans W Moises; William Byerley; Sarah H Shaw; Andrea Mesen; Robin Sherrington; F Anthony O'Neill; Dermot Walsh; Kenneth S Kendler; Jesper Ekelund; Tiina Paunio; Jouko Lönnqvist; Leena Peltonen; Michael C O'Donovan; Michael J Owen; Dieter B Wildenauer; Wolfgang Maier; Gerald Nestadt; Jean-Louis Blouin; Stylianos E Antonarakis; Bryan J Mowry; Jeremy M Silverman; Raymond R Crowe; C Robert Cloninger; Ming T Tsuang; Dolores Malaspina; Jill M Harkavy-Friedman; Dragan M Svrakic; Anne S Bassett; Jennifer Holcomb; Gursharan Kalsi; Andrew McQuillin; Jon Brynjolfson; Thordur Sigmundsson; Hannes Petursson; Elena Jazin; Tomas Zoëga; Tomas Helgason
Journal:  Am J Hum Genet       Date:  2003-06-11       Impact factor: 11.025

View more
  4 in total

1.  No association between NRG1 and ErbB4 genes and psychopathological symptoms of schizophrenia.

Authors:  Sarah Tosato; Martina Zanoni; Chiara Bonetto; Federica Tozzi; Clyde Francks; Elisa Ira; Simona Tomassi; Mariaelena Bertani; Dan Rujescu; Ina Giegling; David St Clair; Michele Tansella; Mirella Ruggeri; Pierandrea Muglia
Journal:  Neuromolecular Med       Date:  2014-08-21       Impact factor: 3.843

2.  A systematic meta-analysis of the association of Neuregulin 1 (NRG1), D-amino acid oxidase (DAO), and DAO activator (DAOA)/G72 polymorphisms with schizophrenia.

Authors:  Vinita Jagannath; Miriam Gerstenberg; Christoph U Correll; Susanne Walitza; Edna Grünblatt
Journal:  J Neural Transm (Vienna)       Date:  2017-09-01       Impact factor: 3.575

3.  Association of chromosome 5q21.3 polymorphisms with the exploratory eye movement dysfunction in schizophrenia.

Authors:  Yuanlin Ma; Jun Li; Hao Yu; Lifang Wang; Tianlan Lu; Chao Pan; Yonghua Han; Dai Zhang; Weihua Yue
Journal:  Sci Rep       Date:  2015-08-05       Impact factor: 4.379

Review 4.  BACE1-Dependent Neuregulin-1 Signaling: An Implication for Schizophrenia.

Authors:  Zhengrong Zhang; Jing Huang; Yong Shen; Rena Li
Journal:  Front Mol Neurosci       Date:  2017-09-25       Impact factor: 5.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.